Related references
Note: Only part of the references are listed.Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Elisabeth Trapp et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Neutrophils escort circulating tumour cells to enable cell cycle progression
Barbara Maria Szczerba et al.
NATURE (2019)
Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells
Yu-Heng Cheng et al.
NATURE COMMUNICATIONS (2019)
Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
Lucile Broncy et al.
CELLS (2019)
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer
Emma Pailler et al.
CLINICAL CANCER RESEARCH (2019)
Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
Claudio Luchini et al.
CANCERS (2019)
Liquid biopsy: novel technologies and clinical applications
Natalie Reimers et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer
Masayuki Kitano et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
M. Ignatiadis et al.
ANNALS OF ONCOLOGY (2018)
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer
Colin M. Court et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Liquid biopsy in pancreatic cancer: the beginning of a new era
Dipesh Kumar Yadav et al.
Oncotarget (2018)
FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies
Stephane Thibodeau et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
Lilian Schwarz et al.
BMC CANCER (2018)
Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status Results of the Prospective CLUSTER Study
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2018)
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk et al.
CLINICAL CANCER RESEARCH (2017)
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P. Lutz et al.
EUROPEAN JOURNAL OF CANCER (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
Birte Kulemann et al.
SCIENTIFIC REPORTS (2017)
Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Takeo Fujii et al.
PLOS ONE (2017)
Molecular characterization and heterogeneity of circulating tumor cells in breast cancer
Anna Jakabova et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui et al.
BRITISH JOURNAL OF CANCER (2017)
Cytologic Characteristics of Circulating Epithelioid Cells in Pancreatic Disease
Matthew W. Rosenbaum et al.
CANCER CYTOPATHOLOGY (2017)
Clinical impact of circulating tumor cells and therapy response in pancreatic cancer
K. Okubo et al.
EJSO (2017)
KRAS mutations in pancreatic circulating tumor cells: a pilot study
Birte Kulemann et al.
TUMOR BIOLOGY (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Sunitha Nagrath et al.
GASTROENTEROLOGY (2016)
Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
Yang Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Julie Earl et al.
BMC CANCER (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis
Colin M. Court et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
Christy E. Cauley et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
Birte Kulemann et al.
PANCREAS (2015)
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer
Yujuan Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer
Massimiliano Bissolati et al.
TUMOR BIOLOGY (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer
Kenneth H. Yu et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
Lu Han et al.
TUMOR BIOLOGY (2014)
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Andrew E. Becker et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F. C. Bidard et al.
ANNALS OF ONCOLOGY (2013)
Endoscopic approach to the diagnosis and treatment of pancreatic disease
William R. Brugge
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L. Khoja et al.
BRITISH JOURNAL OF CANCER (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma
Gregory Sergeant et al.
BMC CANCER (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HER2-Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis et al.
PLOS ONE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Henry K. Lin et al.
CLINICAL CANCER RESEARCH (2010)
Molecular Biomarker Analyses Using Circulating Tumor Cells
Elizabeth A. Punnoose et al.
PLOS ONE (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Pancreatic carcinogenesis
Jan-Bart M. Koorstra et al.
PANCREATOLOGY (2008)
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result
Toshio Kurihara et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantiative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients
Katrin Hoffmann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival
E Soeth et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Molecular markers of early pancreatic cancer
M Goggins
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Share Paper
